Dss, Inc. sold $1.9M of Impact Biomedical (IBO)

Executed Mar 21 2025, disclosed Mar 28 2025, 7 days later, against a two-business-day limit.

Value, as filed

$1.9M

595,762 sh across 5 lots

Executed

Mar 21 2025

the trade date, as filed

Disclosed

Mar 28 2025

7 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DI Dss, Inc. 10% owner profile →

Dss, Inc. (10% owner) filed 3 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in IBO. The largest single filing was $1.9M of IBO (595,762 sh across 5 lots, as filed), executed Mar 21 2025.

The name

IBO IBO IBO · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Dss, Inc. in IBO

IBOSALE IMPACT BIOMEDICAL INC. $846K
890,800 sh × $0.95
Exec Apr 4 2025
Filed Apr 7 2025 · 5:30 PM ET IBOSALE IMPACT BIOMEDICAL INC. –
53,280 sh · price not plausible
Exec Mar 20 2025
Filed Mar 24 2025 · 5:30 PM ET IBOPURCHASE IMPACT BIOMEDICAL INC. $134K
50,000 sh × $2.69
Exec Sep 16 2024
Filed Sep 18 2024 · 5:30 PM ET